RFX-B_NN
is_VBZ
the_DT
gene_NN
responsible_JJ
for_IN
the_DT
most_RBS
common_JJ
cause_NN
of_IN
the_DT
bare_JJ
lymphocyte_NN
syndrome_NN
,_,
an_DT
MHC_NN
class_NN
II_CD
immunodeficiency_NN
-LCB-_-LRB-
published_VBN
erratum_NN
appears_VBZ
in_IN
Immunity_NN
1999_CD
Mar_NNP
;_:
10_CD
-LRB-_-LRB-
3_CD
-RRB-_-RRB-
:_:
399_CD
-RCB-_-RRB-

The_DT
bare_JJ
lymphocyte_NN
syndrome_NN
-LRB-_-LRB-
BLS_NN
-RRB-_-RRB-
is_VBZ
characterized_VBN
by_IN
the_DT
absence_NN
of_IN
MHC_NN
class_NN
II_CD
transcription_NN
and_CC
humoral_JJ
-_:
and_CC
cellular-mediated_JJ
immune_JJ
responses_NNS
to_TO
foreign_JJ
antigens_NNS
._.

Three_CD
of_IN
the_DT
four_CD
BLS_NN
genetic_JJ
complementation_NN
groups_NNS
have_VBP
defects_NNS
in_IN
the_DT
activity_NN
of_IN
the_DT
MHC_NN
class_NN
II_CD
transcription_NN
factor_NN
RFX_NN
._.

We_PRP
have_VBP
purified_VBN
the_DT
RFX_NN
complex_NN
and_CC
sequenced_VBD
its_PRP$
three_CD
subunits_NNS
._.

The_DT
sequence_NN
of_IN
the_DT
smallest_JJS
subunit_NN
describes_VBZ
a_DT
novel_JJ
gene_NN
,_,
termed_VBN
RFX-B_NN
._.

RFX-B_NN
complements_VBZ
the_DT
predominant_JJ
BLS_NN
complementation_NN
group_NN
-LRB-_-LRB-
group_NN
B_NN
-RRB-_-RRB-
and_CC
was_VBD
found_VBN
to_TO
be_VB
mutant_JJ
in_IN
cell_NN
lines_NNS
from_IN
this_DT
BLS_NN
group_NN
._.

The_DT
protein_NN
has_VBZ
no_DT
known_JJ
DNA-binding_JJ
domain_NN
but_CC
does_VBZ
contain_VB
three_CD
ankyrin_NN
repeats_NNS
that_WDT
are_VBP
likely_JJ
to_TO
be_VB
important_JJ
in_IN
protein-protein_JJ
interactions_NNS
._.

